Biotech Stocks

200 stocks · Updated Mar 25, 2026

Biotech stocks represent companies developing therapies using biological processes — including gene therapy, monoclonal antibodies, cell therapy, and mRNA technology. Drug development is expensive and uncertain, but successful drugs can generate massive returns.

#	Stock	Symbol	Company	Price	Change %	Market Cap	Rev Growth	P/E	Gross Margin
1	VRTXVertex Pharmaceuticals Incorporated	VRTX	Vertex Pharmaceuticals Incorporated	$449.67	-0.35%	$115.32B	+9.55%	29.35	+85.39%
2	REGNRegeneron Pharmaceuticals, Inc.	REGN	Regeneron Pharmaceuticals, Inc.	$741.40	+0.67%	$76.15B	+2.51%	17.83	—
3	ARGXargenx SE	ARGX	argenx SE	$677.58	-0.63%	$45.82B	—	—	—
4	ALNYAlnylam Pharmaceuticals, Inc.	ALNY	Alnylam Pharmaceuticals, Inc.	$307.73	+0.36%	$41.40B	+84.95%	153.10	+75.60%
5	INSMInsmed Incorporated	INSM	Insmed Incorporated	$139.26	-3.26%	$29.32B	+152.62%	—	+83.24%
6	UTHRUnited Therapeutics Corporation	UTHR	United Therapeutics Corporation	$532.58	+2.36%	$23.50B	—	27.90	—
7	MRNAModerna, Inc.	MRNA	Moderna, Inc.	$51.55	+0.58%	$20.76B	-29.81%	—	+33.33%
8	ROIVRoivant Sciences Ltd.	ROIV	Roivant Sciences Ltd.	$26.91	-3.58%	$20.08B	-77.83%	—	—
9	RPRXRoyalty Pharma plc	RPRX	Royalty Pharma plc	$45.64	+0.09%	$19.56B	+4.95%	25.50	—
10	RVMDRevolution Medicines, Inc.	RVMD	Revolution Medicines, Inc.	$95.78	-0.92%	$18.80B	—	—	—
11	INCYIncyte Corporation	INCY	Incyte Corporation	$90.81	+0.44%	$18.42B	+23.73%	16.86	+92.75%
12	BBIOBridgeBio Pharma, Inc.	BBIO	BridgeBio Pharma, Inc.	$68.69	-1.29%	$13.46B	—	—	—
13	IONSIonis Pharmaceuticals, Inc.	IONS	Ionis Pharmaceuticals, Inc.	$69.75	-1.46%	$11.76B	-10.26%	—	+96.09%
14	SMMTSummit Therapeutics Inc.	SMMT	Summit Therapeutics Inc.	$15.61	+0.10%	$11.61B	—	—	—
15	JAZZJazz Pharmaceuticals plc	JAZZ	Jazz Pharmaceuticals plc	$183.88	+0.78%	$11.28B	+6.74%	—	—
16	BMRNBioMarin Pharmaceutical Inc.	BMRN	BioMarin Pharmaceutical Inc.	$54.07	-1.22%	$11.25B	+17.03%	32.87	+68.47%
17	EXELExelixis, Inc.	EXEL	Exelixis, Inc.	$41.81	+1.03%	$11.21B	+12.27%	18.02	+96.89%
18	MDGLMadrigal Pharmaceuticals, Inc.	MDGL	Madrigal Pharmaceuticals, Inc.	$446.44	-0.23%	$9.67B	+210.77%	—	—
19	TECHBio-Techne Corporation	TECH	Bio-Techne Corporation	$52.46	+0.94%	$8.46B	—	99.90	+64.65%
20	IBRXImmunityBio, Inc.	IBRX	ImmunityBio, Inc.	$7.47	-21.17%	$8.44B	+1445.12%	—	+99.00%
21	PCVXVaxcyte, Inc.	PCVX	Vaxcyte, Inc.	$54.71	-2.02%	$8.42B	—	—	—
22	AXSMAxsome Therapeutics, Inc.	AXSM	Axsome Therapeutics, Inc.	$157.43	+0.35%	$8.36B	+65.03%	—	—
23	ARWRArrowhead Pharmaceuticals, Inc.	ARWR	Arrowhead Pharmaceuticals, Inc.	$56.25	-0.67%	$8.28B	+10461.30%	36.06	—
24	HALOHalozyme Therapeutics, Inc.	HALO	Halozyme Therapeutics, Inc.	$62.12	-1.14%	$7.99B	+51.60%	24.80	+82.56%
25	CYTKCytokinetics, Incorporated	CYTK	Cytokinetics, Incorporated	$59.91	-1.67%	$7.56B	+2634.98%	—	—
26	KRYSKrystal Biotech, Inc.	KRYS	Krystal Biotech, Inc.	$248.74	-0.54%	$7.52B	+61.12%	36.25	—
27	NUVLNuvalent, Inc.	NUVL	Nuvalent, Inc.	$96.01	-0.37%	$7.40B	+100.00%	—	—
28	KYMRKymera Therapeutics, Inc.	KYMR	Kymera Therapeutics, Inc.	$74.37	-3.16%	$6.81B	-61.18%	—	0.00%
29	ACLXArcellx, Inc.	ACLX	Arcellx, Inc.	$114.63	+0.02%	$6.70B	-85.70%	—	—
30	PRAXPraxis Precision Medicines, Inc.	PRAX	Praxis Precision Medicines, Inc.	$294.21	+0.11%	$6.36B	-100.00%	—	—
31	RYTMRhythm Pharmaceuticals, Inc.	RYTM	Rhythm Pharmaceuticals, Inc.	$82.39	-2.71%	$6.26B	+36.87%	—	+91.61%
32	PTGXProtagonist Therapeutics, Inc.	PTGX	Protagonist Therapeutics, Inc.	$100.56	+2.08%	$6.15B	-85.79%	—	—
33	COGTCogent Biosciences, Inc.	COGT	Cogent Biosciences, Inc.	$34.88	-1.36%	$5.96B	—	—	—
34	PTCTPTC Therapeutics, Inc.	PTCT	PTC Therapeutics, Inc.	$64.88	-2.42%	$5.63B	+92.15%	8.30	—
35	CRSPCRISPR Therapeutics AG	CRSP	CRISPR Therapeutics AG	$46.63	-0.51%	$5.56B	-97.58%	—	—
36	CAICaris Life Sciences, Inc.	CAI	Caris Life Sciences, Inc.	$19.13	-0.67%	$5.30B	+132.75%	—	—
37	IMVTImmunovant, Inc.	IMVT	Immunovant, Inc.	$23.94	-1.89%	$5.29B	—	—	—
38	CELCCelcuity Inc.	CELC	Celcuity Inc.	$103.03	-3.48%	$5.23B	—	—	—
39	CGONCG Oncology, Inc. Common stock	CGON	CG Oncology, Inc. Common stock	$63.83	-1.75%	$5.19B	+409.21%	—	—
40	ERASErasca, Inc.	ERAS	Erasca, Inc.	$14.74	+2.79%	$4.86B	—	—	—
41	XENEXenon Pharmaceuticals Inc.	XENE	Xenon Pharmaceuticals Inc.	$53.30	-2.07%	$4.73B	—	—	—
42	ALKSAlkermes plc	ALKS	Alkermes plc	$28.41	+2.45%	$4.70B	—	—	—
43	TGTXTG Therapeutics, Inc.	TGTX	TG Therapeutics, Inc.	$30.25	-0.72%	$4.62B	+78.00%	9.94	+80.19%
44	FOLDAmicus Therapeutics, Inc.	FOLD	Amicus Therapeutics, Inc.	$14.40	-0.10%	$4.50B	+28.47%	—	+85.67%
45	SRRKScholar Rock Holding Corporation	SRRK	Scholar Rock Holding Corporation	$42.39	-2.73%	$4.49B	—	—	—
46	MIRMMirum Pharmaceuticals, Inc.	MIRM	Mirum Pharmaceuticals, Inc.	$87.37	-2.20%	$4.37B	+49.81%	—	—
47	LGNDLigand Pharmaceuticals Incorporated	LGND	Ligand Pharmaceuticals Incorporated	$201.87	+0.75%	$4.12B	+39.37%	34.21	—
48	APGEApogee Therapeutics, Inc.	APGE	Apogee Therapeutics, Inc.	$72.83	-7.92%	$4.10B	—	—	—
49	CRNXCrinetics Pharmaceuticals, Inc.	CRNX	Crinetics Pharmaceuticals, Inc.	$34.69	0.00%	$4.00B	+640.71%	—	—
50	TERNTerns Pharmaceuticals, Inc.	TERN	Terns Pharmaceuticals, Inc.	$49.86	+0.45%	$3.93B	—	—	—

Showing 1-50 of 200 stocks

Get Your Daily Market Recap

TickFlow Daily delivers the top gainers, losers, and signals to your inbox every day at market close. Free.

Frequently Asked Questions

What is a biotech stock?

A company developing therapies using biological processes like gene therapy, antibodies, and mRNA technology.

How risky are biotech stocks?

Very — drug development is expensive with high failure rates. Binary outcomes from clinical trials create extreme volatility.

What is the difference between biotech and pharma?

Biotech uses biological processes; pharma uses chemical processes. In practice, large biotechs operate much like pharma companies.

Related Stock Lists

Pharmaceutical Stocks

Best Healthcare Stocks

Best Biotech Stocks